Wapnick Pamela
Chief Financial Officer at MGX
- Sold, on record
- $41k
- Dollars the filings state
- Form 4 sales
- 9
- Latest Sep 8, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MGXMetagenomi Therapeutics, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale MGXNo planDec 5, 2024 2024
Sold 1,559 shares at $1.86 ($3k)
Wapnick Pamela, Chief Financial Officer
No 10b5-1 planSold 2.5% of holdings ($117k position)61,492 shares leftFiling
- 2 Form 4 sale MGXNo planMar 5, 2025 +90 days
Sold 1,808 shares at $1.87 ($3k)
Wapnick Pamela, Chief Financial Officer
No 10b5-1 planSold 2.9% of holdings ($115k position)59,684 shares leftFiling
- 3 Form 4 sale MGXNo planJun 6, 2025 +93 days
Sold 1,576 shares at $1.75 ($3k)
Wapnick Pamela, Chief Financial Officer
No 10b5-1 planSold 2.1% of holdings ($129k position)72,108 shares left0.9x usual sizeFiling
- 4 Form 4 sale MGXNo planSep 5, 2025 +91 days
Sold 1,576 shares at $1.81 ($3k)
Wapnick Pamela, Chief Financial Officer
No 10b5-1 planSold 2.2% of holdings ($131k position)70,532 shares left0.9x usual sizeFiling
- 5 Form 4 sale MGXNo planDec 5, 2025 +91 days
Sold 1,576 shares at $1.77 ($3k)
Wapnick Pamela, Chief Financial Officer
No 10b5-1 planSold 0.8% of holdings ($337k position)188,956 shares left1x usual sizeFiling
- 6 Form 4 sale MGXNo planMar 5, 2026 +90 days
Sold 1,581 shares at $1.60 ($3k)
Wapnick Pamela, Chief Financial Officer
No 10b5-1 planSold 0.8% of holdings ($302k position)187,375 shares left1x usual sizeFiling
- 7 Form 4 sale MGXNo planJun 5, 2026 +92 days
Sold 2,884 shares at $1.30 ($4k)
Wapnick Pamela, Chief Financial Officer
No 10b5-1 planSold 1.4% of holdings ($275k position)208,491 shares left1.8x usual sizeFiling
- 8 Form 4 sale MGXNo planSep 8, 2026 +95 days
Sold 1,911 shares at $1.16 ($2k)
Wapnick Pamela, Chief Financial Officer
No 10b5-1 planSold 0.9% of holdings ($242k position)206,580 shares left1.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 10, 2026 | MGX | Chief Financial Officer | Form 4 sale | 1,911 | $2k | 0.9% | No plan | SEC |
| Jun 5, 2026 | Jun 10, 2026 | MGX | Chief Financial Officer | Form 4 sale | 2,884 | $4k | 1.4% | No plan | SEC |
| Mar 5, 2026 | Mar 9, 2026 | MGX | Chief Financial Officer | Form 4 sale | 1,581 | $3k | 0.8% | No plan | SEC |
| Dec 5, 2025 | Dec 8, 2025 | MGX | Chief Financial Officer | Form 4 sale | 1,576 | $3k | 0.8% | No plan | SEC |
| Sep 5, 2025 | Dec 1, 2025 | MGX | Chief Financial Officer | Form 4 sale | 1,576 | $3k | 2.2% | No plan | SEC |
| Jun 6, 2025 | Jun 9, 2025 | MGX | Chief Financial Officer | Form 4 sale | 1,576 | $3k | 2.1% | No plan | SEC |
| Mar 5, 2025 | Mar 7, 2025 | MGX | Chief Financial Officer | Form 4 sale | 1,808 | $3k | 2.9% | No plan | SEC |
| Dec 5, 2024 | Dec 6, 2024 | MGX | Chief Financial Officer | Form 4 sale | 1,559 | $3k | 2.5% | No plan | SEC |
| Sep 5, 2024 | Sep 6, 2024 | MGX | Chief Financial Officer | Form 4 sale | 6,265 | $18k | 9.0% | No plan | SEC |